AAPL337.02-2.73 (-0.80%) ▼|ABBV265.08-0.13 (-0.05%) ▼|ABT103.49-0.20 (-0.19%) ▼|ACN183.52-0.20 (-0.11%) ▼|ADBE240.69+2.44 (+1.02%) ▲|AMAT474.38+1.92 (+0.41%) ▲|AMD614.61-9.16 (-1.47%) ▼|AMGN406.09-4.15 (-1.01%) ▼|AMT170.78-4.47 (-2.55%) ▼|AMZN249.27-5.71 (-2.24%) ▼|AVGO354.99-9.55 (-2.62%) ▼|AXP301.96-3.11 (-1.02%) ▼|BA199.93+2.21 (+1.12%) ▲|BAC56.00-0.20 (-0.36%) ▼|BKNG155.90-8.32 (-5.07%) ▼|BLK1,060.89-5.77 (-0.54%) ▼|BMY61.15-1.10 (-1.77%) ▼|BNY149.51-0.66 (-0.44%) ▼|BRK-B507.17+3.68 (+0.73%) ▲|C131.93-0.54 (-0.41%) ▼|CAT812.02+4.01 (+0.50%) ▲|CL85.93-1.12 (-1.29%) ▼|CMCSA22.55+0.13 (+0.58%) ▲|COF196.10-4.45 (-2.22%) ▼|COP128.09+2.82 (+2.25%) ▲|COST904.70+5.29 (+0.59%) ▲|CRM237.58+4.30 (+1.84%) ▲|CSCO106.43-0.01 (-0.01%) ▼|CVS85.86-1.24 (-1.42%) ▼|CVX205.51+3.10 (+1.53%) ▲|DE709.48+6.36 (+0.90%) ▲|DHR221.56+0.47 (+0.21%) ▲|DIS103.46-0.36 (-0.35%) ▼|DUK114.17-2.14 (-1.84%) ▼|EMR154.59+0.40 (+0.26%) ▲|FDX291.50-4.44 (-1.50%) ▼|GD343.33-0.06 (-0.02%) ▼|GE319.80+0.58 (+0.18%) ▲|GEV951.82+1.54 (+0.16%) ▲|GILD151.37-1.30 (-0.85%) ▼|GM83.77+0.32 (+0.38%) ▲|GOOG334.98-12.43 (-3.58%) ▼|GOOGL337.83-13.33 (-3.80%) ▼|GS936.36-13.13 (-1.38%) ▼|HD296.72-8.63 (-2.83%) ▼|HON212.57+0.72 (+0.34%) ▲|IBM232.76+1.38 (+0.60%) ▲|INTC122.60-1.26 (-1.02%) ▼|INTU286.80-5.55 (-1.90%) ▼|ISRG398.30-3.79 (-0.94%) ▼|JNJ269.17-0.02 (-0.01%) ▼|JPM337.53-2.47 (-0.73%) ▼|KO88.09-0.52 (-0.59%) ▼|LIN469.72+4.81 (+1.03%) ▲|LLY1,150.99-19.15 (-1.64%) ▼|LMT524.68+2.34 (+0.45%) ▲|LOW191.36-4.72 (-2.41%) ▼|LRCX307.28-3.35 (-1.08%) ▼|MA559.92+4.03 (+0.73%) ▲|MCD238.32-12.03 (-4.81%) ▼|MDLZ61.44+0.36 (+0.59%) ▲|MDT89.30-1.47 (-1.62%) ▼|META744.10+7.51 (+1.02%) ▲|MMM170.30+1.00 (+0.59%) ▲|MO68.95+0.31 (+0.45%) ▲|MRK148.08-2.83 (-1.88%) ▼|MS198.39-1.79 (-0.89%) ▼|MSFT500.59+2.59 (+0.52%) ▲|MU1,071.88-24.28 (-2.22%) ▼|NEE77.02-2.24 (-2.83%) ▼|NFLX71.36-0.80 (-1.11%) ▼|NKE36.05-0.05 (-0.14%) ▼|NOW140.78+3.78 (+2.76%) ▲|NVDA225.51-3.36 (-1.47%) ▼|ORCL144.56-4.64 (-3.11%) ▼|PEP130.18-1.01 (-0.77%) ▼|PFE28.18+0.25 (+0.90%) ▲|PG147.39-0.83 (-0.56%) ▼|PLTR191.79+6.80 (+3.68%) ▲|PM190.84+0.61 (+0.32%) ▲|QCOM197.24-1.03 (-0.52%) ▼|RTX192.19+1.20 (+0.63%) ▲|SBUX94.14-0.97 (-1.02%) ▼|SCHW99.50-0.85 (-0.85%) ▼|SO83.47-1.68 (-1.97%) ▼|SPG204.16-1.79 (-0.87%) ▼|T25.30+0.20 (+0.80%) ▲|TMO665.30+6.78 (+1.03%) ▲|TMUS165.66+3.25 (+2.00%) ▲|TSLA380.12+1.22 (+0.32%) ▲|TXN272.62+1.21 (+0.45%) ▲|UBER69.42-0.47 (-0.67%) ▼|UNH371.29-1.66 (-0.45%) ▼|UNP275.53+1.12 (+0.41%) ▲|UPS95.82-0.05 (-0.05%) ▼|USB58.48-0.96 (-1.62%) ▼|V361.52-0.52 (-0.14%) ▼|VZ46.52+0.07 (+0.15%) ▲|WFC81.90-1.25 (-1.50%) ▼|WMT110.53+0.41 (+0.37%) ▲|XOM161.23+2.52 (+1.59%) ▲|AAPL337.02-2.73 (-0.80%) ▼|ABBV265.08-0.13 (-0.05%) ▼|ABT103.49-0.20 (-0.19%) ▼|ACN183.52-0.20 (-0.11%) ▼|ADBE240.69+2.44 (+1.02%) ▲|AMAT474.38+1.92 (+0.41%) ▲|AMD614.61-9.16 (-1.47%) ▼|AMGN406.09-4.15 (-1.01%) ▼|AMT170.78-4.47 (-2.55%) ▼|AMZN249.27-5.71 (-2.24%) ▼|AVGO354.99-9.55 (-2.62%) ▼|AXP301.96-3.11 (-1.02%) ▼|BA199.93+2.21 (+1.12%) ▲|BAC56.00-0.20 (-0.36%) ▼|BKNG155.90-8.32 (-5.07%) ▼|BLK1,060.89-5.77 (-0.54%) ▼|BMY61.15-1.10 (-1.77%) ▼|BNY149.51-0.66 (-0.44%) ▼|BRK-B507.17+3.68 (+0.73%) ▲|C131.93-0.54 (-0.41%) ▼|CAT812.02+4.01 (+0.50%) ▲|CL85.93-1.12 (-1.29%) ▼|CMCSA22.55+0.13 (+0.58%) ▲|COF196.10-4.45 (-2.22%) ▼|COP128.09+2.82 (+2.25%) ▲|COST904.70+5.29 (+0.59%) ▲|CRM237.58+4.30 (+1.84%) ▲|CSCO106.43-0.01 (-0.01%) ▼|CVS85.86-1.24 (-1.42%) ▼|CVX205.51+3.10 (+1.53%) ▲|DE709.48+6.36 (+0.90%) ▲|DHR221.56+0.47 (+0.21%) ▲|DIS103.46-0.36 (-0.35%) ▼|DUK114.17-2.14 (-1.84%) ▼|EMR154.59+0.40 (+0.26%) ▲|FDX291.50-4.44 (-1.50%) ▼|GD343.33-0.06 (-0.02%) ▼|GE319.80+0.58 (+0.18%) ▲|GEV951.82+1.54 (+0.16%) ▲|GILD151.37-1.30 (-0.85%) ▼|GM83.77+0.32 (+0.38%) ▲|GOOG334.98-12.43 (-3.58%) ▼|GOOGL337.83-13.33 (-3.80%) ▼|GS936.36-13.13 (-1.38%) ▼|HD296.72-8.63 (-2.83%) ▼|HON212.57+0.72 (+0.34%) ▲|IBM232.76+1.38 (+0.60%) ▲|INTC122.60-1.26 (-1.02%) ▼|INTU286.80-5.55 (-1.90%) ▼|ISRG398.30-3.79 (-0.94%) ▼|JNJ269.17-0.02 (-0.01%) ▼|JPM337.53-2.47 (-0.73%) ▼|KO88.09-0.52 (-0.59%) ▼|LIN469.72+4.81 (+1.03%) ▲|LLY1,150.99-19.15 (-1.64%) ▼|LMT524.68+2.34 (+0.45%) ▲|LOW191.36-4.72 (-2.41%) ▼|LRCX307.28-3.35 (-1.08%) ▼|MA559.92+4.03 (+0.73%) ▲|MCD238.32-12.03 (-4.81%) ▼|MDLZ61.44+0.36 (+0.59%) ▲|MDT89.30-1.47 (-1.62%) ▼|META744.10+7.51 (+1.02%) ▲|MMM170.30+1.00 (+0.59%) ▲|MO68.95+0.31 (+0.45%) ▲|MRK148.08-2.83 (-1.88%) ▼|MS198.39-1.79 (-0.89%) ▼|MSFT500.59+2.59 (+0.52%) ▲|MU1,071.88-24.28 (-2.22%) ▼|NEE77.02-2.24 (-2.83%) ▼|NFLX71.36-0.80 (-1.11%) ▼|NKE36.05-0.05 (-0.14%) ▼|NOW140.78+3.78 (+2.76%) ▲|NVDA225.51-3.36 (-1.47%) ▼|ORCL144.56-4.64 (-3.11%) ▼|PEP130.18-1.01 (-0.77%) ▼|PFE28.18+0.25 (+0.90%) ▲|PG147.39-0.83 (-0.56%) ▼|PLTR191.79+6.80 (+3.68%) ▲|PM190.84+0.61 (+0.32%) ▲|QCOM197.24-1.03 (-0.52%) ▼|RTX192.19+1.20 (+0.63%) ▲|SBUX94.14-0.97 (-1.02%) ▼|SCHW99.50-0.85 (-0.85%) ▼|SO83.47-1.68 (-1.97%) ▼|SPG204.16-1.79 (-0.87%) ▼|T25.30+0.20 (+0.80%) ▲|TMO665.30+6.78 (+1.03%) ▲|TMUS165.66+3.25 (+2.00%) ▲|TSLA380.12+1.22 (+0.32%) ▲|TXN272.62+1.21 (+0.45%) ▲|UBER69.42-0.47 (-0.67%) ▼|UNH371.29-1.66 (-0.45%) ▼|UNP275.53+1.12 (+0.41%) ▲|UPS95.82-0.05 (-0.05%) ▼|USB58.48-0.96 (-1.62%) ▼|V361.52-0.52 (-0.14%) ▼|VZ46.52+0.07 (+0.15%) ▲|WFC81.90-1.25 (-1.50%) ▼|WMT110.53+0.41 (+0.37%) ▲|XOM161.23+2.52 (+1.59%) ▲|

12.6 C

New York

Thursday, September 24, 2026

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages America’s Car-Mart, Inc. Investors to Inquire About Securities Class Action Investigation – CRMT

NWPX Infrastructure Names John Schillie Vice President and General Manager of NWPX Park

Ultimate Longevity Center Launches in Australia, Pushing Global Footprint Past 300 Territories

Tag: years

Ipsen receives positive CHMP opinion for Cabometyx® in previously treated advanced neuroendocrine tumors

PARIS, FRANCE, 20 June 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for Cabometyx® (cabozantinib) for adult patients with unresectable or metastatic, well differentiated extra-pancreatic (epNET) and pancreatic (pNET) neuroendocrine tumors who have progressed following at least one prior systemic therapy other than somatostatin analogues. This recommendation is based on results from the CABINET Phase III trial presented at the European Society of Medical Oncology (ESMO) Congress 2024 and published in the New England Journal of Medicine.^3,⁴ A final decision on the approval in the European Union is expected in the coming months.

GirlStyle Unveils Inaugural “GirlStyle NextGen Glowing Awards 2025,” Illuminating the Future of Beauty

HONG KONG, June 20, 2025 /PRNewswire/ -- The beauty industry marks a significant milestone! GirlStyle, a leading female lifestyle information platform under PressLogic, proudly...

McGee Family Entrusts Six-Decade Legacy to Harwood Auto Group with Guidance from Performance Brokerage Services

PETERBOROUGH, ON, June 20, 2025 /PRNewswire/ -- After more than 60 years serving the Peterborough community, the McGee family has completed the sale of Jack...

Deakin University GIFT City Campus, India, announced ‘Winner’ at Economic Times Education Excellence Awards 2025

NEW DELHI, June 20, 2025 /PRNewswire/ -- Deakin University is proud to announce that its GIFT City Campus in Gandhinagar, India, has been awarded...

Sigma Enterprises Company and IRISS Join Forces to Advance Industrial Reliability and Safety Across the UAE

ABU DHABI, UAE, June 20, 2025 /PRNewswire/ -- IRISS, a global leader in electrical maintenance safety devices and condition-based monitoring (CBM) technologies, has entered a...

LPS and QAX Announce Strategic Partnership for Cybersecurity, Unveiling Security Operation Centre and End-to-End Security Services

The duo's first joint Security Operation Centre (SOC) in Hong Kong addresses the urgent need for advanced cybersecurity defenses amidst surging cyber threats.The new SOC...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsYears

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages America’s Car-Mart, Inc. Investors to Inquire About Securities Class Action Investigation – CRMT

NWPX Infrastructure Names John Schillie Vice President and General Manager of NWPX Park

Ultimate Longevity Center Launches in Australia, Pushing Global Footprint Past 300 Territories

Tag: years

Ipsen receives positive CHMP opinion for Cabometyx® in previously treated advanced neuroendocrine tumors

GirlStyle Unveils Inaugural “GirlStyle NextGen Glowing Awards 2025,” Illuminating the Future of Beauty

McGee Family Entrusts Six-Decade Legacy to Harwood Auto Group with Guidance from Performance Brokerage Services

Deakin University GIFT City Campus, India, announced ‘Winner’ at Economic Times Education Excellence Awards 2025

Sigma Enterprises Company and IRISS Join Forces to Advance Industrial Reliability and Safety Across the UAE

LPS and QAX Announce Strategic Partnership for Cybersecurity, Unveiling Security Operation Centre and End-to-End Security Services

New Global Aesthetics Report: A Shift Towards Facial Surgery Globally as Eyelid Ranks Top Procedure

Tariff Dodging Complaints Soar—Surprised?

eBay and Vestiaire Beg for Tariff Mercy

BC Tech Pioneers Quality Upgrade in PV Industry

Dupixent® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)

Avoid These Costly Social Security Mistakes: A Strategic Guide for Investors

Cochlear celebrates 30 Years in China and the launch of the world’s first and only smart hearing implant system

NEC Indonesia Introduces Integrated Command Control Centre for Industrial Estate at the 9th HKI National Conference 2025

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us